All partners attended the 2-day meeting, filled with enthusiasm and collaboration as we planned the first year of the project. Over 2020, we’ll be focused on planning for our two clinical trials: PREV-HAP and TREAT-HAP, which will start in the next year in France, Spain and Greece. We’ll also be setting up the omics studies to help better characterize patients at risk of HAP. Financial and administrative issues, as well as communication and dissemination strategy, were also discussed.
HAP2 kick-off meeting
13/01/20 - 14/01/20
The HAP2 team came together at the Castle of the Dukes of Brittany in Nantes (France) on 13-14 January 2020 to officially kick off the project.